Ascendis Pharma A/S Adjustments For Decrease Increase In Inventories
Ascendis Pharma A/S (ASND) reported Adjustments For Decrease Increase In Inventories of -EUR 5.92 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-11.
Financial Statements › Notes › Inventory
ifrs-full:AdjustmentsForDecreaseIncreaseInInventories · last filed 2026-02-11
- Ascendis Pharma A/S adjustments for decrease increase in inventories for the quarter ending 2025-12-31 was 501.00K EUR.
- Ascendis Pharma A/S adjustments for decrease increase in inventories for the quarter ending 2025-09-30 was 1.35M EUR.
- Ascendis Pharma A/S adjustments for decrease increase in inventories for the quarter ending 2025-06-30 was -10.31M EUR.
- Ascendis Pharma A/S adjustments for decrease increase in inventories for the quarter ending 2025-03-31 was 2.54M EUR.
| Period end | Adjustments For Decrease Increase In Inventories 3 month | Adjustments For Decrease Increase In Inventories 6 month | Adjustments For Decrease Increase In Inventories 9 month | Adjustments For Decrease Increase In Inventories 12 month |
|---|---|---|---|---|
| 2025-12-31 | 501.00K EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-11 | 1.85M EUR derived: sum of 2 quarters · filed 2026-02-11 | -8.46M EUR derived: sum of 3 quarters · filed 2026-02-11 | -5.92M EUR 20-F · filed 2026-02-11 |
| 2025-09-30 | 1.35M EUR derived: 6-K 9 month − 6-K 6 month · filed 2025-11-12 | -8.96M EUR derived: sum of 2 quarters · filed 2025-11-12 | -6.42M EUR 6-K · filed 2025-11-12 | -36.60M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2025-06-30 | -10.31M EUR derived: 6-K 6 month − 6-K 3 month · filed 2025-08-07 | -7.77M EUR 6-K · filed 2025-08-07 | -37.95M EUR derived: sum of 3 quarters · filed 2026-02-11 | -52.18M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2025-03-31 | 2.54M EUR 6-K · filed 2025-05-01 | -27.64M EUR derived: sum of 2 quarters · filed 2026-02-11 | -41.87M EUR derived: sum of 3 quarters · filed 2026-02-11 | -60.39M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-12-31 | -30.18M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-11 | -44.41M EUR derived: sum of 2 quarters · filed 2026-02-11 | -62.93M EUR derived: sum of 3 quarters · filed 2026-02-11 | -86.68M EUR 20-F · filed 2026-02-11 |
| 2024-09-30 | -14.23M EUR derived: 6-K 9 month − 6-K 6 month · filed 2025-11-12 | -32.75M EUR derived: sum of 2 quarters · filed 2025-11-12 | -56.50M EUR 6-K · filed 2025-11-12 | -76.30M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-06-30 | -18.52M EUR derived: 6-K 6 month − 6-K 3 month · filed 2025-08-07 | -42.27M EUR 6-K · filed 2025-08-07 | -62.07M EUR derived: sum of 3 quarters · filed 2026-02-11 | -83.28M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-03-31 | -23.75M EUR 6-K · filed 2025-05-01 | -43.55M EUR derived: sum of 2 quarters · filed 2026-02-11 | -64.76M EUR derived: sum of 3 quarters · filed 2026-02-11 | -81.83M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2023-12-31 | -19.80M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-11 | -41.01M EUR derived: sum of 2 quarters · filed 2026-02-11 | -58.08M EUR derived: sum of 3 quarters · filed 2026-02-11 | -78.26M EUR 20-F · filed 2026-02-11 |
| 2023-09-30 | -21.21M EUR derived: 6-K 9 month − 6-K 6 month · filed 2024-11-14 | -38.28M EUR derived: sum of 2 quarters · filed 2024-11-14 | -58.46M EUR 6-K · filed 2024-11-14 | -85.16M EUR derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-06-30 | -17.07M EUR derived: 6-K 6 month − 6-K 3 month · filed 2024-09-03 | -37.25M EUR 6-K · filed 2024-09-03 | -63.94M EUR derived: sum of 3 quarters · filed 2025-02-12 | -66.60M EUR derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-03-31 | -20.18M EUR 6-K · filed 2024-05-02 | -46.88M EUR derived: sum of 2 quarters · filed 2025-02-12 | -49.53M EUR derived: sum of 3 quarters · filed 2025-02-12 | -58.41M EUR derived: sum of 4 quarters · filed 2025-02-12 |
| 2022-12-31 | -26.70M EUR derived: 20-F 12 month − 6-K 9 month · filed 2025-02-12 | -29.35M EUR derived: sum of 2 quarters · filed 2025-02-12 | -38.24M EUR derived: sum of 3 quarters · filed 2025-02-12 | -55.27M EUR 20-F · filed 2025-02-12 |
| 2022-09-30 | -2.65M EUR derived: 6-K 9 month − 6-K 6 month · filed 2023-11-07 | -11.54M EUR derived: sum of 2 quarters · filed 2023-11-07 | -28.57M EUR 6-K · filed 2023-11-07 | -48.71M EUR derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-06-30 | -8.89M EUR derived: 6-K 6 month − 6-K 3 month · filed 2023-09-05 | -25.92M EUR 6-K · filed 2023-09-05 | -46.05M EUR derived: sum of 3 quarters · filed 2024-02-07 | -101.32M EUR derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-03-31 | -17.03M EUR 6-K · filed 2023-04-27 | -37.17M EUR derived: sum of 2 quarters · filed 2024-02-07 | -92.44M EUR derived: sum of 3 quarters · filed 2024-02-07 | -92.44M EUR derived: sum of 4 quarters · filed 2024-02-07 |
| 2021-12-31 | -20.14M EUR derived: 20-F 12 month − 6-K 9 month · filed 2024-02-07 | -75.41M EUR derived: sum of 2 quarters · filed 2024-02-07 | -75.41M EUR derived: sum of 3 quarters · filed 2024-02-07 | -75.41M EUR 20-F · filed 2024-02-07 |
| 2021-09-30 | -55.27M EUR derived: 6-K 9 month − 6-K 6 month · filed 2022-11-02 | -55.27M EUR derived: sum of 2 quarters · filed 2022-11-02 | -55.27M EUR 6-K · filed 2022-11-02 | |
| 2021-06-30 | 0.00 EUR derived: 6-K 6 month − 6-K 3 month · filed 2022-08-10 | 0.00 EUR 6-K · filed 2022-08-10 | ||
| 2021-03-31 | 0.00 EUR 6-K · filed 2022-05-11 |